Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rhabdomyosarcoma 6 Wilms Tumor 3 Rhabdomyosarcoma, Embryonal 3 Sarcoma 2 Rhabdomyosarcoma, Alveolar 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Pleuropulmonary blastoma 1 Hydatidiform Mole, Invasive 1 Histiocytoma, Malignant Fibrous 1 Gestational Trophoblastic Disease 1 Dermatofibrosarcoma 1 Choriocarcinoma 1 Beckwith-Wiedemann Syndrome 1

Interventions

Temozolomide 12 Vincristine 9 Irinotecan 8 Cyclophosphamide 8 cabozantinib 6 X-Rays 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 Etoposide 5 regorafenib 4 fludarabine 4 Radiotherapy 4 Phantoms, Imaging 4 Ifosfamide 4 Doxorubicin 4 Radiation 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 olaparib 2 liposomal doxorubicin 2 ivosidenib 2 irinotecan sucrosofate 2 etoposide phosphate 2 abemaciclib 2 Zoledronic Acid 2 Topotecan 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Dactinomycin × 1 year × Clear all

NCT07194044 2026-05-15

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡